ReviewAnnals of the New York Academy of Sciences2026
Toward Meta-Omics Governance of the Urban Microbiome Commons.
Review in Annals of the New York Academy of Sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Urban microbial communities are undergoing directional homogenization across soils, wildlife gut microbiota, and human exposure pathways, yet no monitoring framework exists to track this loss or govern the probiotic city interventions now scaling without ecological oversight. I argue that the urban microbiome constitutes an "invisible commons": a shared, depletable resource whose depletion goes unaccounted for because it has never been made measurable. The meta-omics community has the tools to change this. I propose five monitoring priorities and six immediately deployable indicators and show that the governance architecture required to convert these measurements into decisions already exists in conservation biology. What is missing is not new science but the decision to apply existing methods to this domain. With antibiotic resistance causing over one million deaths annually and probiotic city interventions advancing without resistance gene screening, that decision is overdue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.